Ocular Therapeutix Inc. (Nasdaq: OCUL) named Antony Mattessich as its next chief executive. The stock price plunged $1.39 to close at $10.15.
Ocular Therapeutix names new CEO
June 23, 2017 at 17:51 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|